| HIV care in times of the COVID-19 crisis—Where are we now in Central and Eastern Europe? JD Kowalska, A Skrzat-Klapaczyńska, D Bursa, T Balayan, J Begovac, ... International journal of infectious diseases 96, 311-314, 2020 | 102 | 2020 |
| Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national … E Dolmazashvili, A Abutidze, N Chkhartishvili, M Karchava, L Sharvadze, ... European journal of gastroenterology & hepatology 29 (11), 1223-1230, 2017 | 95 | 2017 |
| National progress toward hepatitis C elimination—Georgia, 2015–2016 L Gvinjilia MMWR. Morbidity and mortality weekly report 65, 2016 | 88 | 2016 |
| Assessment of quality of life in people living with HIV in Georgia E Karkashadze, MA Gates, N Chkhartishvili, J DeHovitz, T Tsertsvadze International journal of STD & AIDS 28 (7), 672-678, 2017 | 74 | 2017 |
| HIV care in Central and Eastern Europe: How close are we to the target? D Gokengin, C Oprea, J Begovac, A Horban, AN Zeka, D Sedlacek, ... International Journal of Infectious Diseases 70, 121-130, 2018 | 67 | 2018 |
| Linkage and retention in HCV care for HIV‐infected populations: early data from the DAA era R Sacks‐Davis, JS Doyle, A Rauch, C Beguelin, AE Pedrana, ... Journal of the International AIDS Society 21, e25051, 2018 | 54 | 2018 |
| Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium L Bansi-Matharu, A Phillips, C Oprea, K Grabmeier-Pfistershammer, ... The Lancet HIV 8 (11), e711-e722, 2021 | 44 | 2021 |
| High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment M Karchava, J Waldenström, M Parker, R Hallack, L Sharvadze, ... Hepatology Research 45 (13), 1292-1298, 2015 | 43 | 2015 |
| Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia N Chkhartishvili, RR Kempker, N Dvali, L Abashidze, L Sharavdze, ... BMC infectious diseases 13, 1-7, 2013 | 43 | 2013 |
| Three years of progress toward achieving hepatitis C elimination in the country of Georgia, April 2015–March 2018 T Tsertsvadze, A Gamkrelidze, N Chkhartishvili, A Abutidze, L Sharvadze, ... Clinical Infectious Diseases 71 (5), 1263-1268, 2020 | 41 | 2020 |
| Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989–2012 N Chkhartishvili, L Sharvadze, O Chokoshvili, N Bolokadze, N Rukhadze, ... AIDS research and human retroviruses 30 (6), 560-566, 2014 | 39 | 2014 |
| Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting L Greenberg, L Ryom, G Wandeler, K Grabmeier-Pfistershammer, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 83 (3), 240-250, 2020 | 34 | 2020 |
| Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents DM Byonanebye, MN Polizzotto, M Law, K Petoumenos, N Rose, ... Aids 35 (Supplement 2), 869-882, 2021 | 33 | 2021 |
| The EuroSIDA study: 25 years of scientific achievements K Laut, O Kirk, J Rockstroh, A Phillips, B Ledergerber, J Gatell, B Gazzard, ... HIV medicine 21 (2), 71-83, 2020 | 33 | 2020 |
| Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals L Peters, K Laut, C Resnati, S Del Campo, C Leen, K Falconer, ... Aids 32 (14), 1995-2004, 2018 | 33 | 2018 |
| The cascade of care in the E astern E uropean country of G eorgia N Chkhartishvili, L Sharavdze, O Chokoshvili, JA DeHovitz, C Del Rio, ... HIV medicine 16 (1), 62-66, 2015 | 30 | 2015 |
| Late presentation of HIV infection in the country of Georgia: 2012-2015 N Chkhartishvili, O Chokoshvili, N Bolokadze, M Tsintsadze, L Sharvadze, ... PLoS One 12 (10), e0186835, 2017 | 25 | 2017 |
| Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia N Dvali, MM Parker, N Chkhartishvili, L Sharvadze, N Gochitashvili, ... Journal of medical virology 84 (7), 1002-1008, 2012 | 20 | 2012 |
| Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus L Greenberg, L Ryom, B Neesgaard, G Wandeler, T Staub, M Gisinger, ... Clinical Infectious Diseases 73 (7), e2323-e2333, 2021 | 19 | 2021 |
| Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 K Laut, L Shepherd, R Radoi, I Karpov, M Parczewski, C Mussini, F Maltez, ... Eurosurveillance 23 (21), 1700382, 2018 | 19 | 2018 |
Tengiz TsertsvadzeProfessor of Medicine, Ivane Javakhishvili Tbilisi State UniversityVerified email at gol.ge
